Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
President Barack Obama and Republican presidential contender Rick Santorum have finally managed to find something they agree on. Despite their many differences, they see eye to eye on the notion that the tax system should favor manufacturing over other sectors of the economy.
I don’t know how many times I’ve seen liberal commentators look back with nostalgia to the days when a young man fresh out of high school or military service could get a well-paying job on an assembly line at a unionized auto factory that could carry him through to a...
Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.
Turning back the clock to a less efficient economy to save certain manufacturing jobs is not the answer. Have our workforce participate in this dynamic new economy.
This is an all too familiar story, the FDA impeding useful innovations in the US entrepreneurs here are forced to test promising medical devices in costly animal studies for years before they can advance their products into clinical trials. In response, American device makers are moving their business overseas.
Japan's economic performance has largely been written off over the past two decades. It shouldn't be—reform could build on the country's strong fundamentals.
The federal government is a powerful entity, but try as it might it cannot repeal the laws of supply and demand. So don’t blame the drug makers or the banks; blame the politicians in Washington and their inability to see that price "controls" can’t control the larger market.
Every day patients receive treatments that do not work properly. For many this means no relief from symptoms, but for some death is the result. Yet concerted action against such products is limited. Before we can discuss why that's the case, I will attempt to explain what kind of products don’t work, and what we should call them.








